Publications from Consortia

Kappos, L.; Freedman, M. S.; Polman, C. H.; Edan, G.; Hartung, H.-P.; Miller, D. H.; Montalbán, X.; Barkhof, F.; Radü, E.-W.; Metzig, C. et al.; Bauer, L.; Lanius, V.; Sandbrink, R.; Pohl, C.; BENEFIT Study Group; Villringer, A.: Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial. Lancet Neurology 8 (11), pp. 987 - 997 (2009)

Bensimon, G.; Ludolph, A.; Agid, Y.; Vidailhet, M.; Payan, C.; Leigh, N. P.; NNIPPS Study Group ; Villringer, A.: Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: The NNIPPS study. Brain 132 (1), pp. 156 - 171 (2009)